Shanghai, China

Gaoqiang Hu

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Unitris Biopharma Co., Ltd.. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gaoqiang Hu. Retrieved from https://idiyas.com/inventor/gaoqiang-hu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovative Contributions of Inventor Gaoqiang Hu

Introduction: Gaoqiang Hu, an accomplished inventor based in Shanghai, China, has made significant strides in the pharmaceutical field. His work focuses on synthesizing compounds vital for medical applications, showcasing his expertise and innovative mindset.

Latest Patents: Notably, Gaoqiang holds a patent for an intermediate for synthesizing caspofungin, a crucial antifungal agent. This invention details a preparation method that includes the represented formula (I), allowing for the efficient production of caspofungin. This innovation is vital for enhancing the pharmaceutical industry’s ability to combat fungal infections.

Career Highlights: Gaoqiang Hu is affiliated with Unitris Biopharma Co., Ltd., where he utilizes his skills in research and development. His experience and dedication have contributed to advancing therapeutic solutions in healthcare.

Collaborations: Throughout his career, Gaoqiang has worked alongside talented colleagues such as Fuyao Zhang and Xiaoming Shen. Their collaboration fosters a creative environment that stimulates progress and enhances the quality of their innovative projects.

Conclusion: In summary, Gaoqiang Hu's work represents a promising avenue for medical advancements, particularly in antifungal therapies. His inventive spirit and commitment to research continue to make a significant impact in the field of pharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…